{"gene":"SOX18","run_date":"2026-06-10T07:46:38","timeline":{"discoveries":[{"year":1995,"finding":"SOX18 protein binds sequence-specifically to the Sox DNA-binding motif AACAAAG and contains a distinct 95 amino acid activation domain (amino acids 160-225) that mediates trans-activation of gene expression through this motif, as demonstrated by bacterially expressed protein and GAL4-SOX18 fusion assays.","method":"In vitro DNA binding assay with bacterially expressed protein; GAL4 fusion trans-activation assay","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution of DNA binding and mapped activation domain using GAL4 fusions, single lab but multiple orthogonal methods","pmids":["7651823"],"is_preprint":false},{"year":2000,"finding":"Point mutations in Sox18 (missense and premature truncation) in two different ragged (Ra) mouse alleles abolish transcriptional trans-activation activity relative to wild-type in vitro, establishing Sox18 as the causative gene for cardiovascular and hair follicle defects in ragged mice.","method":"In vitro transcription assay; sequencing of Ra alleles; genetic linkage analysis","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro functional assay combined with genetic linkage, replicated across two alleles","pmids":["10742113"],"is_preprint":false},{"year":2000,"finding":"Sox18-null mice have no cardiovascular defects and only a mild coat defect, indicating that the severe ragged phenotype is due to a dominant-negative effect of the mutant SOX18 proteins rather than haploinsufficiency, and suggesting functional redundancy with Sox7 and/or Sox17.","method":"Gene targeting (Sox18-null mice); phenotypic analysis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic knockout with defined phenotypic readout; conclusion supported by comparison with dominant alleles","pmids":["11094083"],"is_preprint":false},{"year":2001,"finding":"SOX18 directly interacts with the MADS box transcription factor MEF2C in endothelial cell nuclei; MEF2C potentiates SOX18-mediated transcription and regulates the SOX18 activation domain. Ragged mutant SOX18 proteins (Ra, RaJ) fail to interact with MEF2C, explaining the dominant-negative effect.","method":"Co-immunoprecipitation; co-localization in endothelial cells; co-transfection transcription assays","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct protein-protein interaction confirmed by co-IP and functional co-transfection assays, with mechanistic follow-up using mutant proteins","pmids":["11554755"],"is_preprint":false},{"year":2001,"finding":"Sox18 is transiently expressed in capillary endothelial cells during the proliferative phase of wound healing angiogenesis in granulation tissue, with identical distribution to Flk-1, but is absent from mature unwounded vessels, establishing Sox18 as a marker and potential regulator of inducible angiogenesis.","method":"In situ hybridization; immunostaining in mouse skin wounds","journal":"Laboratory investigation","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct localization by ISH and IHC, single lab, no functional manipulation","pmids":["11454981"],"is_preprint":false},{"year":2001,"finding":"SOX18 directly activates the mu-opioid receptor (mor) distal promoter by binding to multiple Sox consensus motifs within the promoter enhancer, as shown by gel supershift and concentration-dependent luciferase reporter assays.","method":"Gel supershift assay; luciferase reporter assay with SOX18 overexpression","journal":"Molecular pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — direct DNA binding and transactivation shown in cell-based assay, single lab, single study","pmids":["11353810"],"is_preprint":false},{"year":2003,"finding":"Single-base deletion mutations in Sox18 in the opossum (Ra-op) and ragged-like (Ragl) alleles cause C-terminal frameshifts that abolish transcriptional trans-activation and impair interaction with partner protein MEF2C, acting in a dominant-negative fashion.","method":"Sequencing; in vitro transcription assay; MEF2C interaction assay","journal":"Genesis","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple alleles characterized with functional validation of transactivation loss and MEF2C interaction impairment","pmids":["12748961"],"is_preprint":false},{"year":2003,"finding":"SOX18 directly binds the VCAM-1 promoter and trans-activates VCAM-1 expression; naturally occurring Sox18 mutant (Ra-Op) attenuates VCAM-1 expression in vitro and in vivo in lung, skin, and skeletal muscle, identifying VCAM-1 as a downstream transcriptional target of SOX18.","method":"Transfection; site-specific mutagenesis; gel shift assay; quantitative RT-PCR in Ra-Op mice","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — direct promoter binding by EMSA, site-directed mutagenesis, and in vivo validation in mutant mice","pmids":["14634005"],"is_preprint":false},{"year":2006,"finding":"Sox17 and Sox18 have redundant functions in postnatal neovascularization: Sox17(+/-)Sox18(-/-) double mutant mice show reduced neovascularization in liver sinusoids and kidney vasa recta, and primary endothelial cells from these mice are defective in endothelial sprouting and vascular remodeling in vitro.","method":"Double mutant mouse generation; histology; in vitro angiogenesis assay with primary endothelial cells","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis via double-mutant mice with defined vascular phenotype and in vitro functional follow-up","pmids":["16895970"],"is_preprint":false},{"year":2007,"finding":"Sox18 contains a novel 9-amino acid transactivation motif in its C-terminal charged block that mediates interaction with transcriptional cofactor TAF9 and constitutes a strong additional transactivation domain, explaining previously contradictory data on Sox18 mutations.","method":"Deletion mapping; GAL4 fusion reporter assays; TAF9 interaction analysis","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 1–2 / Weak — functional domain mapping by reporter assay and cofactor interaction identified, single lab","pmids":["17603017"],"is_preprint":false},{"year":2007,"finding":"In zebrafish, sox18 and sox7 play redundant but collectively essential roles in establishing arteriovenous identity; simultaneous morpholino knockdown of both genes causes arteriovenous fusions and loss of venous/arterial identity markers, while single knockdown has minimal effect.","method":"Morpholino knockdown in zebrafish; transgenic reporter lines; molecular marker analysis","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic redundancy demonstrated by double morphant phenotype with arteriovenous marker analysis, replicated by independent zebrafish lab","pmids":["18094332"],"is_preprint":false},{"year":2007,"finding":"Sox17 and Sox18 have redundant roles in early cardiovascular development in mice: Sox17/Sox18 double-null embryos display more severe defects in anterior dorsal aorta and head/cervical microvasculature than Sox17 single-null, corresponding to sites of weak Sox7 expression.","method":"Double knockout mouse generation; whole-mount PECAM staining","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic double knockout with defined vascular phenotypes and epistasis mapping","pmids":["17610846"],"is_preprint":false},{"year":2008,"finding":"Sox18 acts as a molecular switch to induce differentiation of lymphatic endothelial cells: it is expressed in cardinal vein cells that co-express Prox1 and form lymphatic vessels; Sox18 directly activates Prox1 transcription by binding to its proximal promoter; overexpression of Sox18 in blood vascular endothelial cells induces Prox1 and other lymphatic markers; Sox18-null embryos on a sensitized background show complete blockade of lymphatic endothelial differentiation from the cardinal vein.","method":"Promoter binding assay; overexpression in endothelial cells; Sox18-null mouse embryo analysis; cellular lineage tracing","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — direct promoter binding, gain-of-function, and loss-of-function experiments with defined lymphatic differentiation phenotype","pmids":["18931657"],"is_preprint":false},{"year":2008,"finding":"In zebrafish, simultaneous knockdown of Sox7 and Sox18 causes dysmorphogenesis of the proximal aorta and arteriovenous shunts; morphants display ectopic venous Flt4 marker in the dorsal aorta and reduced artery-specific markers EphrinB2a and Gridlock, suggesting Sox7/Sox18 control arteriovenous identity by regulating Gridlock expression.","method":"Morpholino knockdown in zebrafish; gene expression analysis by ISH and RT-PCR","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — double morphant phenotype replicated across two zebrafish labs with molecular marker analysis","pmids":["18377889"],"is_preprint":false},{"year":2009,"finding":"Sox7 and Sox17 can functionally substitute for SOX18 in vitro and in vivo as strain-specific modifiers: they are not normally expressed during lymphatic development but are activated specifically in the absence of SOX18 function only in certain mouse strains, revealing a novel compensatory upregulation mechanism.","method":"Genetic modifier analysis; in vitro functional substitution assays; expression analysis in Sox18-null mice on different strain backgrounds","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 / Strong — mechanistic epistasis combined with in vitro and in vivo functional rescue experiments","pmids":["19515696"],"is_preprint":false},{"year":2009,"finding":"In Ra-Op embryos, SOX18 dysfunction causes enlarged surface capillaries and endothelial barrier breaches by 12.5 dpc with endothelial hyperplasia and impaired pericyte recruitment; downstream targets MMP7, IL7R, and N-cadherin are reduced, implicating SOX18 in transcriptional regulation of genes required for microvascular maturation.","method":"Ultrastructural analysis (EM); immunofluorescence; molecular expression analysis in Ra-Op embryos","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — multiple orthogonal methods (EM, IHC, gene expression) in a defined mutant model, single lab","pmids":["19429912"],"is_preprint":false},{"year":2008,"finding":"SOX18 is a potential target for anti-angiogenic cancer therapy: disruption of Sox18 function (Sox18-null or dominant-negative Sox18RaOp mice) reduces allograft tumor growth and microvessel density; dominant-negative SOX18 impairs HUVEC proliferation, migration, and capillary tube formation via disruption of the actin cytoskeleton.","method":"Allograft tumor model in Sox18-null and Sox18RaOp mice; BrdU incorporation; MTS assay; Boyden chamber migration; capillary tube formation in vitro","journal":"Journal of the National Cancer Institute","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple functional readouts in vitro and in vivo, but mechanistic detail limited to actin cytoskeleton disruption","pmids":["16882943"],"is_preprint":false},{"year":2010,"finding":"EGR1 transcription factor directly activates the SOX18 promoter: three EGR1 binding sites between -89 and +29 bp relative to the transcriptional start site are functionally required for EGR1-induced SOX18 transcription, as shown by in vitro binding assays and mutational analysis.","method":"SOX18 promoter reporter assays; in vitro binding assays; site-directed mutagenesis of EGR1 binding sites","journal":"Experimental & molecular medicine","confidence":"Medium","confidence_rationale":"Tier 1–2 / Weak — in vitro binding and functional mutagenesis, single lab","pmids":["20054233"],"is_preprint":false},{"year":2008,"finding":"Transcription factors Sp3 and ZBP-89 down-regulate, while NF-Y up-regulates, human SOX18 promoter activity by binding the SOX18 promoter region (-200 to -162 bp relative to ATG), as demonstrated by in vitro binding assays and co-transfection experiments.","method":"In vitro binding assays; co-transfection reporter assays; mithramycin A treatment","journal":"Molecular biology reports","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — direct binding and functional transcription assays, single lab","pmids":["18496767"],"is_preprint":false},{"year":2012,"finding":"SOX18 directly activates MMP7 transcription in endothelial cells (demonstrated by promoter reporter assay, EMSA, and ChIP), and also regulates guidance molecules ephrin B2 and semaphorin 3G; SOX18 and MMP7 are co-expressed in blood vessels of human skin.","method":"Adenoviral overexpression; microarray; ChIP; EMSA; reporter gene assays; RT-PCR; immunohistochemistry","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — direct target validation by ChIP, EMSA, and promoter reporter assays with multiple orthogonal methods","pmids":["22292085"],"is_preprint":false},{"year":2013,"finding":"VEGFD modulates SOX18-mediated transcription through MEK-ERK signaling, enhancing nuclear concentration and transcriptional activity of SOX18 in vascular endothelial cells; genetic interaction between Vegfd and Sox18 is required for normal vascular development in both zebrafish and mice.","method":"Zebrafish double morphant; Sox18/Vegfd double knockout mice; cell-based SOX18 transcription assay; signaling pathway analysis","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic interaction in two species combined with molecular mechanism (MAPK-ERK modulation of SOX18 nuclear activity)","pmids":["24269955"],"is_preprint":false},{"year":2013,"finding":"Sox18 genetically interacts with VegfC to regulate lymphangiogenesis: combined partial knockdown of sox18 and vegfc in zebrafish has synergistic effects on venous and lymphatic sprouting from the cardinal vein, and Sox18 is required specifically for lymphangiogenesis after arteriovenous differentiation.","method":"Zebrafish morpholino knockdown; inducible dominant-negative Sox18 transgenic zebrafish; thoracic duct formation analysis","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic epistasis in zebrafish with inducible dominant-negative model and morpholino double knockdown","pmids":["23520166"],"is_preprint":false},{"year":2014,"finding":"Sox18 maintains pulmonary endothelial barrier integrity in response to laminar shear stress by upregulating Claudin-5 (CLDN5): shear stress increases Sox18 expression; overexpression of Sox18 enhances trans-endothelial resistance; depletion of Claudin-5 abolishes the Sox18-mediated barrier effect.","method":"Trans-endothelial resistance measurement; Sox18 overexpression and knockdown; Claudin-5 siRNA; ovine shunt model","journal":"Journal of cellular physiology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — functional barrier assay with loss- and gain-of-function, downstream target validation by siRNA rescue","pmids":["24677020"],"is_preprint":false},{"year":2016,"finding":"Crystal structure of the SOX18 HMG box bound to a Prox1 DNA element determined at 1.75Å resolution reveals water structure, DNA contact interface, and non-canonical DNA backbone conformations; decoy DNAs based on the Prox1 binding site inhibit SOX18 DNA binding in vitro and suppress SOX18-dependent VCAM1 promoter activity in cells.","method":"X-ray crystallography; in vitro DNA binding assay; luciferase reporter assay in COS7 cells; serum stability and nuclease resistance assays","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure at high resolution with functional validation by decoy inhibition in cell-based reporter assay","pmids":["26939885"],"is_preprint":false},{"year":2016,"finding":"NF-κB (p65) transcriptionally represses SOX18 expression by binding to a SOX18 promoter sequence between -1,082 and -1,073 bp; this NF-κB-mediated SOX18 downregulation leads to reduced CLDN5 and pulmonary endothelial barrier disruption in LPS-induced acute lung injury; peroxynitrite contributes to NF-κB activation in this context.","method":"Promoter reporter assays; ChIP for NF-κB; SOX18 overexpression in HLMVECs and mouse lung; CLDN5 siRNA rescue; LPS in vivo models","journal":"American journal of respiratory cell and molecular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP, promoter mapping, gain-of-function in vitro and in vivo, and downstream target rescue","pmids":["29115856"],"is_preprint":false},{"year":2017,"finding":"A small molecule (Sm4) disrupts a discrete subset of SOX18 protein-protein interactions involving the HMG DNA-binding domain, including SOX18-RBPJ interaction, selectively suppresses SOX18 transcriptional outputs in vitro, interferes with vascular development in zebrafish, and reduces tumour vascular density and metastatic spread in a mouse breast cancer model.","method":"Proteomic interactome analysis; biophysical binding assays; zebrafish vascular development assay; mouse breast cancer allograft model; reporter gene assay","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods (proteomics, biophysics, cell-based reporter, in vivo models) in a single comprehensive study","pmids":["28137359"],"is_preprint":false},{"year":2017,"finding":"Small-molecule SOX18 inhibitors identified from a marine extract library interfere with the SOX18 HMG DNA-binding domain, disrupt HMG-dependent protein-protein interaction with RBPJ, and perturb SOX18 transcriptional activity in a cell-based reporter system.","method":"Marine extract library screen; in vitro binding assay; cell-based SOX18 reporter gene assay","journal":"Cell chemical biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — biochemical binding assay and cell-based reporter, single lab, multiple compounds tested","pmids":["28163017"],"is_preprint":false},{"year":2017,"finding":"SOX18 regulates the differentiation of dermal papilla in all hair types: dominant-negative Sox18 (opossum) prevents dermal papilla from inducing hair in regeneration assays; downstream effectors WNT5A and TNC are identified by microarray as potential SOX18 targets regulating epidermal WNT signalling.","method":"Dominant-negative Sox18 mouse; fate tracing; microarray; hair regeneration assay with dermal papilla spheres","journal":"Development","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — dominant-negative loss-of-function with defined hair differentiation phenotype and microarray target identification, single lab","pmids":["28512199"],"is_preprint":false},{"year":2018,"finding":"SOX18 uniquely forms homodimers (among SOXF proteins) via a novel motif in the vicinity of the C-terminus of the DNA-binding region; SOX18 dimerization drives enrichment at endothelial-specific chromatin loci containing SOX dimer binding motifs; a small-molecule inhibitor that disrupts dimerization reduces SOX18 transcriptional activity.","method":"In vitro binding assays; split-GFP dimerization reporter in zebrafish; genome-wide ChIP-seq; SOX18 dimerization inhibitor; motif insertion into SOX7 monomer","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro binding, in vivo split-GFP, genome-wide ChIP-seq, and pharmacological disruption with functional readout","pmids":["30335167"],"is_preprint":false},{"year":2018,"finding":"miR-7-5p targets the SOX18 3'UTR to suppress SOX18 protein expression, and SOX18 transcriptionally activates gp130 (a subunit of the IL-6 receptor), activating gp130/JAK2/STAT3 signaling in pancreatic cancer cells.","method":"Luciferase reporter assay (miRNA target); Western blot; ChIP assay for SOX18 on gp130 promoter; gp130/JAK2/STAT3 pathway analysis","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — ChIP for direct target validation and pathway analysis, single lab","pmids":["29408481"],"is_preprint":false},{"year":2019,"finding":"R(+)-propranolol is a small-molecule inhibitor of the SOX18 transcription factor, acting independently of beta-adrenergic receptor blockade; this mechanism explains propranolol's therapeutic effect in infantile hemangioma and HLTRS syndrome, and is demonstrated in a mouse model of HLTRS (corneal neo-vascularisation rescue) and a patient-derived hemangioma model.","method":"Mouse HLTRS model; in vitro infantile hemangioma model; molecular mechanism dissection distinguishing R(+) from S(-) enantiomer","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 / Strong — enantiomer specificity ruling out adrenergic mechanism, in vivo and patient-derived model rescue, convergent evidence","pmids":["31358114"],"is_preprint":false},{"year":2020,"finding":"SOX18 transcriptionally activates MCAM and CCL7, which are required for SOX18-mediated gastric cancer invasion and metastasis; a CCL7-CCR1-SOX18 positive feedback loop operates via the ERK/ELK1 pathway, where CCL7-CCR1 upregulates SOX18 expression.","method":"ChIP; luciferase reporter assay; gain/loss-of-function in GC cells; in vivo mouse models; rescue experiments with MCAM and CCL7","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP for direct target identification, rescue experiments, and signaling pathway dissection, single lab","pmids":["32616889"],"is_preprint":false},{"year":2020,"finding":"TGF-β1 upregulates SOX18 expression by activating the Smad2/3 complex; SOX18 then transactivates CXCL12 and PD-L1, promoting immunosuppressive tumor microenvironment in hepatocellular carcinoma.","method":"ChIP; dual-luciferase reporter assay; flow cytometry; orthotopic allografts; hepatocyte-specific knockin/knockout mice; AAV8 delivery","journal":"Gastroenterology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — ChIP and reporter assays for direct transcriptional targets, Smad2/3 upstream pathway, multiple in vivo models","pmids":["38417530"],"is_preprint":false},{"year":2020,"finding":"SLC12A5 interacts with and stabilizes SOX18 protein, and the SLC12A5-SOX18 complex upregulates MMP7 to enhance bladder urothelial carcinoma progression.","method":"Co-immunoprecipitation; in vitro and in vivo functional assays; gene expression analysis","journal":"Cancer science","confidence":"Medium","confidence_rationale":"Tier 3 / Weak — single Co-IP demonstrating interaction, functional assays performed but mechanistic detail limited","pmids":["32449280"],"is_preprint":false},{"year":2020,"finding":"SOX18 enhances KSHV genome copy numbers and binds to viral origins of replication in lymphatic endothelial cells; chemical or genetic inhibition of SOX18 reduces KSHV genome copies, supporting a role for SOX18 in viral genome maintenance.","method":"ChIP for SOX18 on viral origins of replication; genetic depletion; chemical inhibition; quantification of viral genome copies","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and functional depletion experiments with defined viral copy number readout, single lab","pmids":["32518203"],"is_preprint":false},{"year":2021,"finding":"Dominant-negative SOX18 (SOX18RaOp) disrupts multiple functional layers of wild-type SOX18: it alters target gene selection genome-wide, impairs chromatin binding dynamics, and poisons the wild-type SOX18 interactome including regulatory nodes SOX7 and MEF2C; revealed by single-molecule imaging in living cells, genomics, and proteomics.","method":"Single-molecule imaging (three assays); genome-wide ChIP/ATAC-seq; proteomics interactome analysis; comparison of wild-type vs. dominant-negative in living cells","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal cutting-edge methods in a single comprehensive mechanistic study","pmids":["34570228"],"is_preprint":false},{"year":2022,"finding":"NF-κB-mediated repression of Sox18 in LPS-induced acute lung injury requires HDAC1 and HDAC2: selective siRNA depletion of HDACs 1 and 2 prevents LPS-mediated Sox18 repression; HDAC1 associates with a transcription-repressive complex at the NF-κB-binding site of the Sox18 promoter; HDAC1 inhibitor tacedinaline preserves endothelial barrier in vivo.","method":"HDAC siRNA depletion; ChIP for HDAC1 at Sox18 promoter; promoter reporter assays; endothelial permeability assays; mouse LPS model","journal":"Frontiers in physiology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP for chromatin-associated repressor, siRNA depletion, and in vivo rescue, multiple orthogonal methods","pmids":["35991176"],"is_preprint":false},{"year":2022,"finding":"SOX18 loss-of-function mutation (Lys117*) abolishes trans-activation on target genes NR2F2 and GATA4 and terminates synergistic activation between SOX18 and NKX2.5 in a luciferase reporter assay, identifying NR2F2 and GATA4 as direct transcriptional targets of SOX18 relevant to congenital heart disease.","method":"Luciferase reporter assay in HeLa cells; Sanger sequencing; co-transfection with SOX18/NKX2.5","journal":"Diagnostics","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — cell-based reporter assay with defined mutant, single lab","pmids":["36010266"],"is_preprint":false},{"year":2025,"finding":"SOX18 transcriptionally represses PTX3 under physiological conditions; in sepsis-induced cardiomyopathy, RBM15/YTHDF2-mediated m6A modification destabilizes SOX18 mRNA, reducing SOX18 protein, increasing PTX3, and inducing cardiomyocyte pyroptosis.","method":"ChIP; dual-luciferase reporter assay for SOX18-PTX3; m6A-seq; RNA stability assay; co-immunoprecipitation; confocal microscopy; mouse LPS cardiomyocyte model","journal":"Theranostics","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — ChIP and reporter assay for direct target, m6A-seq and RNA stability for PTM mechanism, multiple orthogonal methods in single study","pmids":["40093897"],"is_preprint":false},{"year":2025,"finding":"An endothelial SOX18-mevalonate pathway (MVP) axis regulates infantile hemangioma pathogenesis: R(+)-propranolol suppresses the MVP via SOX18, which is both necessary and sufficient for this suppression; SOX18 regulates SREBP2 and HMG-CoA reductase (HMGCR); nuclear co-localization of SOX18 and SREBP2 is found in IH patient tissue; statins (HMGCR inhibitors) suppress IH vessel formation in a preclinical xenograft model.","method":"Transcriptomic profiling; SOX18 loss- and gain-of-function; IH xenograft model; patient tissue co-localization by IHC","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — transcriptomic, functional loss/gain-of-function, patient tissue validation, and in vivo xenograft model","pmids":["39998898"],"is_preprint":false},{"year":2013,"finding":"TNF-α (as well as IL-1 and LPS) represses Sox18 expression in HUVECs through the NF-κB pathway (p65/RelA subunit); adenoviral expression of IκBα prevents Sox18 downregulation; the responsible SOX18 promoter region is within -1.0 kb of the transcriptional start site.","method":"Adenoviral IκBα overexpression; Sox18 promoter reporter assays; co-transfection with p65","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — promoter reporter and IκBα rescue, single lab, limited mechanistic depth","pmids":["24269235"],"is_preprint":false}],"current_model":"SOX18 is an HMG-box transcription factor that binds the consensus motif AACAAAG and contains multiple transactivation domains (central, and a C-terminal 9-aa TAF9-interacting motif); it functions as a molecular switch for lymphatic endothelial cell differentiation by directly activating Prox1 transcription, and has direct transcriptional targets including VCAM-1, MMP7, CLDN5, CXCL12, PD-L1, gp130, MCAM, and CCL7; it physically interacts with MEF2C (required for vascular transcriptional programs), dimerizes via a unique C-terminal motif to access endothelial-specific chromatin loci, and is regulated upstream by VEGFD-MEK-ERK, TGF-β1-Smad2/3, EGR1, NF-κB (repressor, requiring HDAC1/2), Sp3, ZBP-89 (repressors), and NF-Y (activator); the R(+)-propranolol enantiomer and the small molecule Sm4 inhibit SOX18 activity by disrupting protein-protein interactions, and m6A modification by RBM15/YTHDF2 destabilizes SOX18 mRNA in sepsis; dominant-negative ragged alleles act by impairing MEF2C interaction and poisoning the wild-type SOX18 interactome including SOX7."},"narrative":{"mechanistic_narrative":"SOX18 is an HMG-box transcription factor that orchestrates vascular and lymphatic endothelial development by binding the Sox consensus motif AACAAAG and trans-activating target genes through a mapped central activation domain (residues 160–225) and a C-terminal 9-amino-acid motif that recruits the cofactor TAF9 [PMID:7651823, PMID:17603017]. Its central developmental role is to act as a molecular switch for lymphatic endothelial differentiation, directly activating Prox1 transcription from cardinal vein cells and inducing the lymphatic program when overexpressed in blood vascular endothelium [PMID:18931657]. SOX18 functions within the SOXF family with extensive redundancy: it shares overlapping roles with Sox7 and Sox17 in arteriovenous identity, neovascularization, and early cardiovascular patterning, such that Sox18-null mice are largely normal while combined loss produces severe vascular defects [PMID:11094083, PMID:16895970, PMID:18094332, PMID:17610846]. Beyond Prox1, SOX18 directly activates an endothelial and disease-relevant target repertoire including VCAM-1, MMP7, and the barrier protein Claudin-5 [PMID:14634005, PMID:22292085, PMID:24677020], and it cooperates with the MADS-box factor MEF2C, which potentiates SOX18 activity through its activation domain [PMID:11554755]. SOX18 uniquely homodimerizes among SOXF proteins via a C-terminal motif, and this dimerization drives its enrichment at endothelial-specific chromatin loci [PMID:30335167]. Its activity is shaped by upstream signaling, being enhanced by VEGFD-MEK-ERK signaling that increases nuclear SOX18 [PMID:24269955] and TGF-β1–Smad2/3 [PMID:38417530], and repressed at the promoter by NF-κB acting through HDAC1/2 [PMID:29115856, PMID:35991176]. Dominant-negative \"ragged\" alleles cause cardiovascular and hair follicle defects not by haploinsufficiency but by poisoning the wild-type SOX18 interactome, including loss of MEF2C and SOX7 contacts and disrupted chromatin binding dynamics [PMID:10742113, PMID:11094083, PMID:34570228]. SOX18 is a druggable node: small molecules such as Sm4 and the R(+)-propranolol enantiomer inhibit its protein-protein interactions, explaining propranolol's efficacy in infantile hemangioma and HLTRS syndrome [PMID:28137359, PMID:31358114]. In cancer it drives tumor angiogenesis, invasion, and an immunosuppressive microenvironment through targets including gp130, MCAM, CCL7, CXCL12, and PD-L1 [PMID:16882943, PMID:29408481, PMID:32616889, PMID:38417530].","teleology":[{"year":1995,"claim":"Established SOX18 as a sequence-specific DNA-binding transcriptional activator with a defined activation domain, answering whether it functions directly on gene promoters.","evidence":"In vitro DNA binding with bacterially expressed protein and GAL4-SOX18 fusion trans-activation assays","pmids":["7651823"],"confidence":"High","gaps":["No physiological target genes identified at this stage","Cellular and developmental context unknown"]},{"year":2000,"claim":"Linked SOX18 to cardiovascular and hair follicle development and revealed that disease-causing ragged alleles act dominant-negatively rather than through simple loss of function.","evidence":"Sequencing of Ra alleles with in vitro transcription assays, plus Sox18-null mouse phenotyping","pmids":["10742113","11094083"],"confidence":"High","gaps":["Molecular basis of the dominant-negative effect not yet defined","Identity of redundant compensating factors only inferred"]},{"year":2001,"claim":"Identified MEF2C as a direct SOX18 partner that potentiates its activity and explained the dominant-negative ragged effect as loss of MEF2C interaction.","evidence":"Co-immunoprecipitation, endothelial co-localization, and co-transfection transcription assays with wild-type and mutant SOX18","pmids":["11554755","12748961"],"confidence":"High","gaps":["Structural basis of the SOX18-MEF2C interface not resolved","Whether MEF2C cooperation is needed at all endothelial targets unknown"]},{"year":2003,"claim":"Defined the first direct in vivo endothelial target gene, VCAM-1, establishing SOX18 control of vascular adhesion gene expression.","evidence":"EMSA, site-directed promoter mutagenesis, and qRT-PCR in Ra-Op mutant mice","pmids":["14634005"],"confidence":"High","gaps":["Broader genome-wide target set not yet mapped","Mechanism of target selectivity unknown"]},{"year":2007,"claim":"Resolved redundancy within the SOXF family, showing Sox7/Sox17/Sox18 collectively govern arteriovenous identity and neovascularization across mouse and zebrafish.","evidence":"Double-mutant mice and double-morphant zebrafish with vascular marker analysis (Gridlock, EphrinB2, Flt4)","pmids":["16895970","18094332","17610846","18377889"],"confidence":"High","gaps":["Division of labor among paralogs at specific loci unresolved","Direct downstream effectors of arteriovenous patterning incompletely defined"]},{"year":2007,"claim":"Defined a second transactivation module — a C-terminal 9-aa motif binding TAF9 — reconciling contradictory data on truncating SOX18 mutations.","evidence":"Deletion mapping, GAL4 reporter assays, and TAF9 interaction analysis","pmids":["17603017"],"confidence":"Medium","gaps":["Single lab","Contribution of this domain in vivo not directly tested"]},{"year":2008,"claim":"Established SOX18 as the molecular switch initiating lymphatic endothelial differentiation by directly activating Prox1, the field-defining mechanistic insight.","evidence":"Proximal Prox1 promoter binding, gain-of-function in blood endothelium, and Sox18-null embryo analysis on a sensitized background","pmids":["18931657"],"confidence":"High","gaps":["Upstream signals triggering the switch not fully defined at this stage","Cofactor requirements for Prox1 activation unspecified"]},{"year":2009,"claim":"Explained strain-dependent severity of Sox18 loss through compensatory upregulation of normally silent Sox7/Sox17, and detailed microvascular maturation defects in ragged mutants.","evidence":"Genetic modifier analysis, functional substitution assays, and ultrastructural/expression analysis of Ra-Op embryos (MMP7, IL7R, N-cadherin)","pmids":["19515696","19429912"],"confidence":"High","gaps":["Mechanism that activates compensatory paralog expression unknown","Pericyte recruitment defect not mechanistically linked to specific targets"]},{"year":2010,"claim":"Began mapping upstream transcriptional control of the SOX18 promoter, identifying activators and repressors.","evidence":"Promoter reporter assays, in vitro binding, and mutagenesis for EGR1, Sp3, ZBP-89, and NF-Y","pmids":["20054233","18496767"],"confidence":"Medium","gaps":["In vivo relevance of these regulators not tested","Integration of multiple inputs on the promoter unresolved"]},{"year":2013,"claim":"Connected vascular growth-factor signaling to SOX18, showing VEGFD-MEK-ERK enhances nuclear SOX18 activity and VegfC genetically interacts with sox18 in lymphangiogenesis.","evidence":"Zebrafish and mouse genetic interaction studies with cell-based SOX18 transcription assays; inducible dominant-negative zebrafish","pmids":["24269955","23520166"],"confidence":"High","gaps":["Direct ERK phosphorylation sites on SOX18 not mapped","Quantitative contribution of each signal in vivo unclear"]},{"year":2014,"claim":"Defined a SOX18-Claudin-5 axis maintaining endothelial barrier integrity under shear stress, linking SOX18 to vascular homeostasis beyond development.","evidence":"Trans-endothelial resistance with SOX18 gain/loss-of-function and Claudin-5 siRNA rescue, ovine shunt model","pmids":["24677020"],"confidence":"High","gaps":["Mechanosensing pathway upstream of SOX18 not defined","Other barrier targets not assessed"]},{"year":2016,"claim":"Provided a high-resolution structural basis for SOX18-DNA recognition and demonstrated druggability via DNA decoys, alongside NF-κB-mediated promoter repression in lung injury.","evidence":"1.75Å crystal structure of the HMG box on a Prox1 element with decoy inhibition; ChIP and promoter mapping of NF-κB repression","pmids":["26939885","29115856"],"confidence":"High","gaps":["Full-length protein and dimer structure not solved","Structural basis of cofactor contacts unknown"]},{"year":2017,"claim":"Validated SOX18 protein-protein interactions as a therapeutic vulnerability and identified small molecules (Sm4, marine extracts) and R(+)-propranolol that disrupt them, mechanistically explaining propranolol efficacy in hemangioma and HLTRS.","evidence":"Interactome proteomics, biophysical binding, cell reporters, zebrafish and mouse tumor/HLTRS models; enantiomer-specific dissection","pmids":["28137359","28163017","31358114"],"confidence":"High","gaps":["Precise binding sites of inhibitors on SOX18 not all resolved","Selectivity against other SOXF proteins incompletely characterized"]},{"year":2018,"claim":"Discovered that SOX18 uniquely homodimerizes among SOXF proteins via a C-terminal motif, and that dimerization drives enrichment at endothelial-specific chromatin loci.","evidence":"In vitro binding, split-GFP dimerization in zebrafish, genome-wide ChIP-seq, motif transfer to monomeric SOX7, and a dimerization-disrupting inhibitor","pmids":["30335167"],"confidence":"High","gaps":["Whether all endothelial targets require dimerization unknown","Structural detail of the dimer interface not solved"]},{"year":2021,"claim":"Defined the multilayered mechanism of the dominant-negative ragged allele, showing it rewires target selection, chromatin binding dynamics, and the wild-type interactome including SOX7 and MEF2C.","evidence":"Single-molecule live-cell imaging, genome-wide ChIP/ATAC-seq, and interactome proteomics comparing wild-type and SOX18RaOp","pmids":["34570228"],"confidence":"High","gaps":["Stoichiometry of poisoning in heterozygous tissue not quantified","Therapeutic reversibility not tested"]},{"year":2025,"claim":"Extended SOX18 mechanism to disease metabolism and post-transcriptional control, linking it to a mevalonate-pathway axis in hemangioma and to m6A-mediated mRNA destabilization in sepsis cardiomyopathy.","evidence":"Transcriptomics with SOX18 gain/loss and IH xenografts; ChIP, m6A-seq, RNA stability, and Co-IP in LPS cardiomyocyte models (SREBP2/HMGCR; RBM15/YTHDF2/PTX3)","pmids":["39998898","40093897"],"confidence":"High","gaps":["Generalizability of the mevalonate axis beyond hemangioma unknown","Whether m6A regulation operates in vascular tissues untested"]},{"year":null,"claim":"How SOX18's two transactivation domains, homodimerization, and partner contacts (MEF2C, TAF9, RBPJ, SOX7) are integrated structurally and combinatorially to achieve locus-specific endothelial gene selection remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No full-length or dimer-DNA-cofactor structure","Rules governing target selectivity across cell types undefined","Quantitative hierarchy of upstream signaling inputs unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,12,7,19,32]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,23,28]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[3,20]}],"pathway":[{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[12,8,11]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,7,19]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[20,32]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[30,31,32]}],"complexes":[],"partners":["MEF2C","SOX7","TAF9","RBPJ","NKX2.5","SLC12A5"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P35713","full_name":"Transcription factor SOX-18","aliases":[],"length_aa":384,"mass_kda":40.9,"function":"Transcriptional activator that binds to the consensus sequence 5'-AACAAAG-3' in the promoter of target genes and plays an essential role in embryonic cardiovascular development and lymphangiogenesis. Activates transcription of PROX1 and other genes coding for lymphatic endothelial markers. Plays an essential role in triggering the differentiation of lymph vessels, but is not required for the maintenance of differentiated lymphatic endothelial cells. Plays an important role in postnatal angiogenesis, where it is functionally redundant with SOX17. Interaction with MEF2C enhances transcriptional activation. Besides, required for normal hair development","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/P35713/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SOX18","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SOX18","total_profiled":1310},"omim":[{"mim_id":"621248","title":"PULMONARY HYPERTENSION, PRIMARY, 7; PPH7","url":"https://www.omim.org/entry/621248"},{"mim_id":"612202","title":"SRY-BOX 7; SOX7","url":"https://www.omim.org/entry/612202"},{"mim_id":"612082","title":"CAPICUA TRANSCRIPTIONAL REPRESSOR; CIC","url":"https://www.omim.org/entry/612082"},{"mim_id":"610928","title":"SRY-BOX 17; SOX17","url":"https://www.omim.org/entry/610928"},{"mim_id":"607823","title":"HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS","url":"https://www.omim.org/entry/607823"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"heart muscle","ntpm":77.1}],"url":"https://www.proteinatlas.org/search/SOX18"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P35713","domains":[{"cath_id":"1.10.30.10","chopping":"89-149","consensus_level":"high","plddt":97.4664,"start":89,"end":149}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P35713","model_url":"https://alphafold.ebi.ac.uk/files/AF-P35713-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P35713-F1-predicted_aligned_error_v6.png","plddt_mean":62.03},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SOX18","jax_strain_url":"https://www.jax.org/strain/search?query=SOX18"},"sequence":{"accession":"P35713","fasta_url":"https://rest.uniprot.org/uniprotkb/P35713.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P35713/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P35713"}},"corpus_meta":[{"pmid":"18931657","id":"PMC_18931657","title":"Sox18 induces development of the lymphatic vasculature in mice.","date":"2008","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/18931657","citation_count":449,"is_preprint":false},{"pmid":"12740761","id":"PMC_12740761","title":"Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia.","date":"2003","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12740761","citation_count":308,"is_preprint":false},{"pmid":"10742113","id":"PMC_10742113","title":"Mutations in Sox18 underlie cardiovascular and hair follicle defects in ragged mice.","date":"2000","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10742113","citation_count":190,"is_preprint":false},{"pmid":"16895970","id":"PMC_16895970","title":"Redundant roles of Sox17 and Sox18 in postnatal angiogenesis in mice.","date":"2006","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/16895970","citation_count":175,"is_preprint":false},{"pmid":"18094332","id":"PMC_18094332","title":"Sox18 and Sox7 play redundant roles in vascular development.","date":"2007","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/18094332","citation_count":165,"is_preprint":false},{"pmid":"17610846","id":"PMC_17610846","title":"Redundant roles of Sox17 and Sox18 in early cardiovascular development of mouse embryos.","date":"2007","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17610846","citation_count":154,"is_preprint":false},{"pmid":"18377889","id":"PMC_18377889","title":"Zebrafish Sox7 and Sox18 function together to control arterial-venous identity.","date":"2008","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18377889","citation_count":105,"is_preprint":false},{"pmid":"11094083","id":"PMC_11094083","title":"Mice null for sox18 are viable and display a mild coat defect.","date":"2000","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11094083","citation_count":103,"is_preprint":false},{"pmid":"38417530","id":"PMC_38417530","title":"TGF-β1-Induced SOX18 Elevation Promotes Hepatocellular Carcinoma Progression and Metastasis Through Transcriptionally Upregulating PD-L1 and CXCL12.","date":"2024","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/38417530","citation_count":98,"is_preprint":false},{"pmid":"19515696","id":"PMC_19515696","title":"Sox7 and Sox17 are strain-specific modifiers of the lymphangiogenic defects caused by Sox18 dysfunction in mice.","date":"2009","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/19515696","citation_count":84,"is_preprint":false},{"pmid":"26630461","id":"PMC_26630461","title":"Sox7, Sox17, and Sox18 Cooperatively Regulate Vascular Development in the Mouse Retina.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26630461","citation_count":81,"is_preprint":false},{"pmid":"16882943","id":"PMC_16882943","title":"Effect of disrupted SOX18 transcription factor function on tumor growth, vascularization, and endothelial development.","date":"2006","source":"Journal of the National Cancer Institute","url":"https://pubmed.ncbi.nlm.nih.gov/16882943","citation_count":79,"is_preprint":false},{"pmid":"11728880","id":"PMC_11728880","title":"SOX18 and the transcriptional regulation of blood vessel development.","date":"2001","source":"Trends in cardiovascular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/11728880","citation_count":78,"is_preprint":false},{"pmid":"7651823","id":"PMC_7651823","title":"Trans-activation and DNA-binding properties of the transcription factor, Sox-18.","date":"1995","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/7651823","citation_count":77,"is_preprint":false},{"pmid":"16193513","id":"PMC_16193513","title":"SOX7 and SOX18 are essential for cardiogenesis in Xenopus.","date":"2005","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/16193513","citation_count":73,"is_preprint":false},{"pmid":"29115856","id":"PMC_29115856","title":"LPS-induced Acute Lung Injury Involves NF-κB-mediated Downregulation of SOX18.","date":"2018","source":"American journal of respiratory cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/29115856","citation_count":65,"is_preprint":false},{"pmid":"24269955","id":"PMC_24269955","title":"VEGFD regulates blood vascular development by modulating SOX18 activity.","date":"2013","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/24269955","citation_count":64,"is_preprint":false},{"pmid":"7665083","id":"PMC_7665083","title":"Sequence and expression of Sox-18 encoding a new HMG-box transcription factor.","date":"1995","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/7665083","citation_count":58,"is_preprint":false},{"pmid":"28137359","id":"PMC_28137359","title":"Pharmacological targeting of the transcription factor SOX18 delays breast cancer in mice.","date":"2017","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/28137359","citation_count":57,"is_preprint":false},{"pmid":"12748961","id":"PMC_12748961","title":"Sox18 mutations in the ragged mouse alleles ragged-like and opossum.","date":"2003","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/12748961","citation_count":55,"is_preprint":false},{"pmid":"11554755","id":"PMC_11554755","title":"SOX18 directly interacts with MEF2C in endothelial cells.","date":"2001","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11554755","citation_count":53,"is_preprint":false},{"pmid":"26939885","id":"PMC_26939885","title":"Structure and decoy-mediated inhibition of the SOX18/Prox1-DNA interaction.","date":"2016","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/26939885","citation_count":50,"is_preprint":false},{"pmid":"14634005","id":"PMC_14634005","title":"The VCAM-1 gene that encodes the vascular cell adhesion molecule is a target of the Sry-related high mobility group box gene, Sox18.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14634005","citation_count":48,"is_preprint":false},{"pmid":"11454981","id":"PMC_11454981","title":"Sox18 is transiently expressed during angiogenesis in granulation tissue of skin wounds with an identical expression pattern to Flk-1 mRNA.","date":"2001","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/11454981","citation_count":47,"is_preprint":false},{"pmid":"31358114","id":"PMC_31358114","title":"R-propranolol is a small molecule inhibitor of the SOX18 transcription factor in a rare vascular syndrome and hemangioma.","date":"2019","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/31358114","citation_count":47,"is_preprint":false},{"pmid":"28163017","id":"PMC_28163017","title":"Small-Molecule Inhibitors of the SOX18 Transcription Factor.","date":"2017","source":"Cell chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/28163017","citation_count":44,"is_preprint":false},{"pmid":"31825847","id":"PMC_31825847","title":"A Study of High-Grade Serous Ovarian Cancer Origins Implicates the SOX18 Transcription Factor in Tumor Development.","date":"2019","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/31825847","citation_count":44,"is_preprint":false},{"pmid":"24065215","id":"PMC_24065215","title":"Impact of SOX18 expression in cancer cells and vessels on the outcome of invasive ductal breast carcinoma.","date":"2013","source":"Cellular oncology (Dordrecht, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/24065215","citation_count":41,"is_preprint":false},{"pmid":"29408481","id":"PMC_29408481","title":"MiR-7-5p functions as a tumor suppressor by targeting SOX18 in pancreatic ductal adenocarcinoma.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/29408481","citation_count":40,"is_preprint":false},{"pmid":"12165811","id":"PMC_12165811","title":"Expression of human SOX18 in normal tissues and tumors.","date":"2002","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12165811","citation_count":39,"is_preprint":false},{"pmid":"23520166","id":"PMC_23520166","title":"Sox18 genetically interacts with VegfC to regulate lymphangiogenesis in zebrafish.","date":"2013","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/23520166","citation_count":39,"is_preprint":false},{"pmid":"11179689","id":"PMC_11179689","title":"Cloning and functional analysis of the Sry-related HMG box gene, Sox18.","date":"2001","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/11179689","citation_count":38,"is_preprint":false},{"pmid":"16179596","id":"PMC_16179596","title":"Transcription factor SOX18 is expressed in human coronary atherosclerotic lesions and regulates DNA synthesis and vascular cell growth.","date":"2005","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16179596","citation_count":38,"is_preprint":false},{"pmid":"19429912","id":"PMC_19429912","title":"Vascular defects in a mouse model of hypotrichosis-lymphedema-telangiectasia syndrome indicate a role for SOX18 in blood vessel maturation.","date":"2009","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19429912","citation_count":38,"is_preprint":false},{"pmid":"32616889","id":"PMC_32616889","title":"SOX18 promotes gastric cancer metastasis through transactivating MCAM and CCL7.","date":"2020","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/32616889","citation_count":37,"is_preprint":false},{"pmid":"22292085","id":"PMC_22292085","title":"The transcription factor SOX18 regulates the expression of matrix metalloproteinase 7 and guidance molecules in human endothelial cells.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22292085","citation_count":32,"is_preprint":false},{"pmid":"27922675","id":"PMC_27922675","title":"Overexpression of SOX18 promotes prostate cancer progression via the regulation of TCF1, c-Myc, cyclin D1 and MMP-7.","date":"2016","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/27922675","citation_count":32,"is_preprint":false},{"pmid":"17603017","id":"PMC_17603017","title":"A novel 9-amino-acid transactivation domain in the C-terminal part of Sox18.","date":"2007","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17603017","citation_count":32,"is_preprint":false},{"pmid":"20228271","id":"PMC_20228271","title":"Contrasting effects of Sox17- and Sox18-sustained expression at the onset of blood specification.","date":"2010","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/20228271","citation_count":31,"is_preprint":false},{"pmid":"22018271","id":"PMC_22018271","title":"Heterogeneity and degree of TIMP4, GATA4, SOX18, and EGFL7 gene promoter methylation in non-small cell lung cancer and surrounding tissues.","date":"2011","source":"Cancer genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22018271","citation_count":29,"is_preprint":false},{"pmid":"26588701","id":"PMC_26588701","title":"SOX18 Is a Novel Target Gene of Hedgehog Signaling in Cervical Carcinoma Cell Lines.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26588701","citation_count":28,"is_preprint":false},{"pmid":"26396173","id":"PMC_26396173","title":"Silencing NKD2 by promoter region hypermethylation promotes gastric cancer invasion and metastasis by up-regulating SOX18 in human gastric cancer.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26396173","citation_count":28,"is_preprint":false},{"pmid":"27108946","id":"PMC_27108946","title":"Suppression of SOX18 by siRNA inhibits cell growth and invasion of breast cancer cells.","date":"2016","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/27108946","citation_count":26,"is_preprint":false},{"pmid":"26151573","id":"PMC_26151573","title":"Knockdown of SOX18 inhibits the proliferation, migration and invasion of hepatocellular carcinoma cells.","date":"2015","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/26151573","citation_count":26,"is_preprint":false},{"pmid":"24697860","id":"PMC_24697860","title":"Hypotrichosis-lymphedema-telangiectasia-renal defect associated with a truncating mutation in the SOX18 gene.","date":"2014","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24697860","citation_count":26,"is_preprint":false},{"pmid":"25075026","id":"PMC_25075026","title":"SOX18 expression predicts response to platinum-based chemotherapy in ovarian cancer.","date":"2014","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/25075026","citation_count":25,"is_preprint":false},{"pmid":"30335167","id":"PMC_30335167","title":"Homodimerization regulates an endothelial specific signature of the SOX18 transcription factor.","date":"2018","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/30335167","citation_count":24,"is_preprint":false},{"pmid":"26148450","id":"PMC_26148450","title":"Aortic Dilatation Associated With a De Novo Mutation in the SOX18 Gene: Expanding the Clinical Spectrum of Hypotrichosis-Lymphedema-Telangiectasia Syndrome.","date":"2015","source":"The Canadian journal of cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/26148450","citation_count":23,"is_preprint":false},{"pmid":"27666488","id":"PMC_27666488","title":"MicroRNAs modulate the expression of the SOX18 transcript in lung squamous cell carcinoma.","date":"2016","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/27666488","citation_count":22,"is_preprint":false},{"pmid":"32449280","id":"PMC_32449280","title":"SLC12A5 interacts and enhances SOX18 activity to promote bladder urothelial carcinoma progression via upregulating MMP7.","date":"2020","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/32449280","citation_count":22,"is_preprint":false},{"pmid":"32518203","id":"PMC_32518203","title":"Oncogenic Herpesvirus Engages Endothelial Transcription Factors SOX18 and PROX1 to Increase Viral Genome Copies and Virus Production.","date":"2020","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/32518203","citation_count":22,"is_preprint":false},{"pmid":"24677020","id":"PMC_24677020","title":"Sox18 preserves the pulmonary endothelial barrier under conditions of increased shear stress.","date":"2014","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/24677020","citation_count":21,"is_preprint":false},{"pmid":"27757173","id":"PMC_27757173","title":"Methylome analysis for spina bifida shows SOX18 hypomethylation as a risk factor with evidence for a complex (epi)genetic interplay to affect neural tube development.","date":"2016","source":"Clinical epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/27757173","citation_count":20,"is_preprint":false},{"pmid":"29229250","id":"PMC_29229250","title":"Genome-wide transcriptomics analysis identifies sox7 and sox18 as specifically regulated by gata4 in cardiomyogenesis.","date":"2017","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/29229250","citation_count":19,"is_preprint":false},{"pmid":"25290189","id":"PMC_25290189","title":"Adipose tissue-derived stromal cells acquire endothelial-like features upon reprogramming with SOX18.","date":"2014","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/25290189","citation_count":19,"is_preprint":false},{"pmid":"11353810","id":"PMC_11353810","title":"Transcriptional modulation of mouse mu-opioid receptor distal promoter activity by Sox18.","date":"2001","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/11353810","citation_count":19,"is_preprint":false},{"pmid":"30008814","id":"PMC_30008814","title":"Role of the SOX18 protein in neoplastic processes.","date":"2018","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/30008814","citation_count":18,"is_preprint":false},{"pmid":"29115529","id":"PMC_29115529","title":"Influence of miR-7a and miR-24-3p on the SOX18 transcript in lung adenocarcinoma.","date":"2017","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/29115529","citation_count":18,"is_preprint":false},{"pmid":"30555240","id":"PMC_30555240","title":"Upregulation of SOX18 in colorectal cancer cells promotes proliferation and correlates with colorectal cancer risk.","date":"2018","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/30555240","citation_count":16,"is_preprint":false},{"pmid":"34570228","id":"PMC_34570228","title":"A dominant-negative SOX18 mutant disrupts multiple regulatory layers essential to transcription factor activity.","date":"2021","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/34570228","citation_count":16,"is_preprint":false},{"pmid":"29266413","id":"PMC_29266413","title":"Heterogeneous expression and biological function of SOX18 in osteosaroma.","date":"2018","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29266413","citation_count":15,"is_preprint":false},{"pmid":"27127146","id":"PMC_27127146","title":"SOX18 Expression in Non-melanoma Skin Cancer.","date":"2016","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/27127146","citation_count":15,"is_preprint":false},{"pmid":"31527225","id":"PMC_31527225","title":"Transcription Factor SOX18 Promotes Clear Cell Renal Cell Carcinoma Progression and Alleviates Cabozantinib-Mediated Inhibitory Effects.","date":"2019","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/31527225","citation_count":15,"is_preprint":false},{"pmid":"10858556","id":"PMC_10858556","title":"The human SOX18 gene: cDNA cloning and high resolution mapping.","date":"2000","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/10858556","citation_count":15,"is_preprint":false},{"pmid":"31189744","id":"PMC_31189744","title":"Down-regulation of SOX18 inhibits laryngeal carcinoma cell proliferation, migration, and invasion through JAK2/STAT3 signaling.","date":"2019","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/31189744","citation_count":14,"is_preprint":false},{"pmid":"28512199","id":"PMC_28512199","title":"Dominant-negative Sox18 function inhibits dermal papilla maturation and differentiation in all murine hair types.","date":"2017","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/28512199","citation_count":14,"is_preprint":false},{"pmid":"11418236","id":"PMC_11418236","title":"Sox18 expression in blood vessels and feather buds during chicken embryogenesis.","date":"2001","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/11418236","citation_count":14,"is_preprint":false},{"pmid":"26631803","id":"PMC_26631803","title":"A novel SOX18 mutation uncovered in Jordanian patient with hypotrichosis-lymphedema-telangiectasia syndrome by Whole Exome Sequencing.","date":"2015","source":"Molecular and cellular probes","url":"https://pubmed.ncbi.nlm.nih.gov/26631803","citation_count":14,"is_preprint":false},{"pmid":"29184419","id":"PMC_29184419","title":"Interleukin-6 upregulates SOX18 expression in osteosarcoma.","date":"2017","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/29184419","citation_count":13,"is_preprint":false},{"pmid":"26573263","id":"PMC_26573263","title":"SOX18 knockdown suppresses the proliferation and metastasis, and induces the apoptosis of osteosarcoma cells.","date":"2015","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/26573263","citation_count":13,"is_preprint":false},{"pmid":"36620216","id":"PMC_36620216","title":"Loss of SOX18/CLAUDIN5 disrupts the pulmonary endothelial barrier in ventilator-induced lung injury.","date":"2022","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/36620216","citation_count":13,"is_preprint":false},{"pmid":"10807548","id":"PMC_10807548","title":"cDNA cloning, tissue expression, and chromosome mapping of human homolog of SOX18.","date":"2000","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10807548","citation_count":13,"is_preprint":false},{"pmid":"31427562","id":"PMC_31427562","title":"SOX18 Affects Cell Viability, Migration, Invasiveness, and Apoptosis in Hepatocellular Carcinoma (HCC) Cells by Participating in Epithelial-to-Mesenchymal Transition (EMT) Progression and Adenosine Monophosphate Activated Protein Kinase (AMPK)/Mammalian Target of Rapamycin (mTOR).","date":"2019","source":"Medical science monitor : international medical journal of experimental and clinical research","url":"https://pubmed.ncbi.nlm.nih.gov/31427562","citation_count":13,"is_preprint":false},{"pmid":"29307792","id":"PMC_29307792","title":"Further delineation of the SOX18-related Hypotrichosis, Lymphedema, Telangiectasia syndrome (HTLS).","date":"2018","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29307792","citation_count":13,"is_preprint":false},{"pmid":"32762101","id":"PMC_32762101","title":"Hesperetin ameliorates lipopolysaccharide-induced acute lung injury via the miR-410/SOX18 axis.","date":"2020","source":"Journal of biochemical and molecular toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/32762101","citation_count":13,"is_preprint":false},{"pmid":"40093897","id":"PMC_40093897","title":"The m6A modification of SOX18 leads to increased PTX3 and cardiomyocyte pyroptosis in sepsis-induced cardiomyopathy.","date":"2025","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/40093897","citation_count":12,"is_preprint":false},{"pmid":"36732767","id":"PMC_36732767","title":"The maturation of iPS cell-derived brain microvascular endothelial cells by inducible-SOX18 expression.","date":"2023","source":"Fluids and barriers of the CNS","url":"https://pubmed.ncbi.nlm.nih.gov/36732767","citation_count":12,"is_preprint":false},{"pmid":"31260682","id":"PMC_31260682","title":"The role of SOX18 in bladder cancer and its underlying mechanism in mediating cellular functions.","date":"2019","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31260682","citation_count":12,"is_preprint":false},{"pmid":"32703403","id":"PMC_32703403","title":"Long noncoding RNA LINC01194 enhances the malignancy of laryngeal squamous cell carcinoma by sponging miR-655 to increase SOX18 expression.","date":"2020","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/32703403","citation_count":12,"is_preprint":false},{"pmid":"39998898","id":"PMC_39998898","title":"An endothelial SOX18-mevalonate pathway axis enables repurposing of statins for infantile hemangioma.","date":"2025","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/39998898","citation_count":11,"is_preprint":false},{"pmid":"32858034","id":"PMC_32858034","title":"SOX18 exerts tumor-suppressive functions in papillary thyroid carcinoma through inhibition of Wnt/β-catenin signaling.","date":"2020","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/32858034","citation_count":11,"is_preprint":false},{"pmid":"32196572","id":"PMC_32196572","title":"SP1-induced lncRNA LINC00689 overexpression contributes to osteosarcoma progression via the miR-655/SOX18 axis.","date":"2020","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32196572","citation_count":11,"is_preprint":false},{"pmid":"36010266","id":"PMC_36010266","title":"Identification of SOX18 as a New Gene Predisposing to Congenital Heart Disease.","date":"2022","source":"Diagnostics (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/36010266","citation_count":10,"is_preprint":false},{"pmid":"34004439","id":"PMC_34004439","title":"SOX18 enhances the proliferation and migration of airway smooth muscle cells induced by tumor necrosis factor-α via the regulation of Notch1 signaling.","date":"2021","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/34004439","citation_count":10,"is_preprint":false},{"pmid":"30549413","id":"PMC_30549413","title":"A novel autosomal dominant mutation in SOX18 resulting in a fatal case of hypotrichosis-lymphedema-telangiectasia syndrome.","date":"2018","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/30549413","citation_count":9,"is_preprint":false},{"pmid":"20054233","id":"PMC_20054233","title":"Early growth response protein 1 acts as an activator of SOX18 promoter.","date":"2010","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20054233","citation_count":9,"is_preprint":false},{"pmid":"18496767","id":"PMC_18496767","title":"ZBP-89 and Sp3 down-regulate while NF-Y up-regulates SOX18 promoter activity in HeLa cells.","date":"2008","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/18496767","citation_count":9,"is_preprint":false},{"pmid":"32419535","id":"PMC_32419535","title":"Augmented angiogenic transcription factor, SOX18, is associated with asthma exacerbation.","date":"2020","source":"The Journal of asthma : official journal of the Association for the Care of Asthma","url":"https://pubmed.ncbi.nlm.nih.gov/32419535","citation_count":8,"is_preprint":false},{"pmid":"28137360","id":"PMC_28137360","title":"Taking aim at Sox18.","date":"2017","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/28137360","citation_count":8,"is_preprint":false},{"pmid":"29648920","id":"PMC_29648920","title":"Functional domain analysis of SOX18 transcription factor using a single-chain variable fragment-based approach.","date":"2018","source":"mAbs","url":"https://pubmed.ncbi.nlm.nih.gov/29648920","citation_count":8,"is_preprint":false},{"pmid":"35991176","id":"PMC_35991176","title":"NF-κB-dependent repression of Sox18 transcription factor requires the epigenetic regulators histone deacetylases 1 and 2 in acute lung injury.","date":"2022","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/35991176","citation_count":8,"is_preprint":false},{"pmid":"27230943","id":"PMC_27230943","title":"Expression of SOX18 in Mycosis Fungoides.","date":"2017","source":"Acta dermato-venereologica","url":"https://pubmed.ncbi.nlm.nih.gov/27230943","citation_count":7,"is_preprint":false},{"pmid":"24460943","id":"PMC_24460943","title":"Construction and functional analysis of novel dominant-negative mutant of human SOX18 protein.","date":"2013","source":"Biochemistry. Biokhimiia","url":"https://pubmed.ncbi.nlm.nih.gov/24460943","citation_count":7,"is_preprint":false},{"pmid":"24269235","id":"PMC_24269235","title":"TNFα-induced down-regulation of Sox18 in endothelial cells is dependent on NF-κB.","date":"2013","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/24269235","citation_count":7,"is_preprint":false},{"pmid":"35422958","id":"PMC_35422958","title":"SOX18-associated gene signature predicts sepsis outcome.","date":"2022","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/35422958","citation_count":6,"is_preprint":false},{"pmid":"37184032","id":"PMC_37184032","title":"SOX18 meditates the resistance of Bmi1-expressing cells to cetuximab in HNSCC.","date":"2023","source":"Oral diseases","url":"https://pubmed.ncbi.nlm.nih.gov/37184032","citation_count":6,"is_preprint":false},{"pmid":"37511076","id":"PMC_37511076","title":"Targeting SOX18 Transcription Factor Activity by Small-Molecule Inhibitor Sm4 in Non-Small Lung Cancer Cell Lines.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37511076","citation_count":6,"is_preprint":false},{"pmid":"17768012","id":"PMC_17768012","title":"Inhibition of tumor angiogenesis by cell-permeable dominant negative SOX18 mutants.","date":"2007","source":"Medical hypotheses","url":"https://pubmed.ncbi.nlm.nih.gov/17768012","citation_count":6,"is_preprint":false},{"pmid":"37250328","id":"PMC_37250328","title":"SOX18-enforced expression diverts hemogenic endothelium-derived progenitors from T towards NK lymphoid pathways.","date":"2023","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/37250328","citation_count":5,"is_preprint":false},{"pmid":"32662888","id":"PMC_32662888","title":"Significance of SOX18 expression in nonmelanoma skin cancers for prediction of high-risk patients: a preliminary study.","date":"2020","source":"International journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/32662888","citation_count":5,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":47714,"output_tokens":9430,"usd":0.142296,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":19745,"output_tokens":5096,"usd":0.113062,"stage2_stop_reason":"end_turn"},"total_usd":0.255358,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"SOX18 protein binds sequence-specifically to the Sox DNA-binding motif AACAAAG and contains a distinct 95 amino acid activation domain (amino acids 160-225) that mediates trans-activation of gene expression through this motif, as demonstrated by bacterially expressed protein and GAL4-SOX18 fusion assays.\",\n      \"method\": \"In vitro DNA binding assay with bacterially expressed protein; GAL4 fusion trans-activation assay\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution of DNA binding and mapped activation domain using GAL4 fusions, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"7651823\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Point mutations in Sox18 (missense and premature truncation) in two different ragged (Ra) mouse alleles abolish transcriptional trans-activation activity relative to wild-type in vitro, establishing Sox18 as the causative gene for cardiovascular and hair follicle defects in ragged mice.\",\n      \"method\": \"In vitro transcription assay; sequencing of Ra alleles; genetic linkage analysis\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro functional assay combined with genetic linkage, replicated across two alleles\",\n      \"pmids\": [\"10742113\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Sox18-null mice have no cardiovascular defects and only a mild coat defect, indicating that the severe ragged phenotype is due to a dominant-negative effect of the mutant SOX18 proteins rather than haploinsufficiency, and suggesting functional redundancy with Sox7 and/or Sox17.\",\n      \"method\": \"Gene targeting (Sox18-null mice); phenotypic analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic knockout with defined phenotypic readout; conclusion supported by comparison with dominant alleles\",\n      \"pmids\": [\"11094083\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"SOX18 directly interacts with the MADS box transcription factor MEF2C in endothelial cell nuclei; MEF2C potentiates SOX18-mediated transcription and regulates the SOX18 activation domain. Ragged mutant SOX18 proteins (Ra, RaJ) fail to interact with MEF2C, explaining the dominant-negative effect.\",\n      \"method\": \"Co-immunoprecipitation; co-localization in endothelial cells; co-transfection transcription assays\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct protein-protein interaction confirmed by co-IP and functional co-transfection assays, with mechanistic follow-up using mutant proteins\",\n      \"pmids\": [\"11554755\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Sox18 is transiently expressed in capillary endothelial cells during the proliferative phase of wound healing angiogenesis in granulation tissue, with identical distribution to Flk-1, but is absent from mature unwounded vessels, establishing Sox18 as a marker and potential regulator of inducible angiogenesis.\",\n      \"method\": \"In situ hybridization; immunostaining in mouse skin wounds\",\n      \"journal\": \"Laboratory investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct localization by ISH and IHC, single lab, no functional manipulation\",\n      \"pmids\": [\"11454981\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"SOX18 directly activates the mu-opioid receptor (mor) distal promoter by binding to multiple Sox consensus motifs within the promoter enhancer, as shown by gel supershift and concentration-dependent luciferase reporter assays.\",\n      \"method\": \"Gel supershift assay; luciferase reporter assay with SOX18 overexpression\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — direct DNA binding and transactivation shown in cell-based assay, single lab, single study\",\n      \"pmids\": [\"11353810\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Single-base deletion mutations in Sox18 in the opossum (Ra-op) and ragged-like (Ragl) alleles cause C-terminal frameshifts that abolish transcriptional trans-activation and impair interaction with partner protein MEF2C, acting in a dominant-negative fashion.\",\n      \"method\": \"Sequencing; in vitro transcription assay; MEF2C interaction assay\",\n      \"journal\": \"Genesis\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple alleles characterized with functional validation of transactivation loss and MEF2C interaction impairment\",\n      \"pmids\": [\"12748961\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"SOX18 directly binds the VCAM-1 promoter and trans-activates VCAM-1 expression; naturally occurring Sox18 mutant (Ra-Op) attenuates VCAM-1 expression in vitro and in vivo in lung, skin, and skeletal muscle, identifying VCAM-1 as a downstream transcriptional target of SOX18.\",\n      \"method\": \"Transfection; site-specific mutagenesis; gel shift assay; quantitative RT-PCR in Ra-Op mice\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — direct promoter binding by EMSA, site-directed mutagenesis, and in vivo validation in mutant mice\",\n      \"pmids\": [\"14634005\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Sox17 and Sox18 have redundant functions in postnatal neovascularization: Sox17(+/-)Sox18(-/-) double mutant mice show reduced neovascularization in liver sinusoids and kidney vasa recta, and primary endothelial cells from these mice are defective in endothelial sprouting and vascular remodeling in vitro.\",\n      \"method\": \"Double mutant mouse generation; histology; in vitro angiogenesis assay with primary endothelial cells\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis via double-mutant mice with defined vascular phenotype and in vitro functional follow-up\",\n      \"pmids\": [\"16895970\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Sox18 contains a novel 9-amino acid transactivation motif in its C-terminal charged block that mediates interaction with transcriptional cofactor TAF9 and constitutes a strong additional transactivation domain, explaining previously contradictory data on Sox18 mutations.\",\n      \"method\": \"Deletion mapping; GAL4 fusion reporter assays; TAF9 interaction analysis\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Weak — functional domain mapping by reporter assay and cofactor interaction identified, single lab\",\n      \"pmids\": [\"17603017\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"In zebrafish, sox18 and sox7 play redundant but collectively essential roles in establishing arteriovenous identity; simultaneous morpholino knockdown of both genes causes arteriovenous fusions and loss of venous/arterial identity markers, while single knockdown has minimal effect.\",\n      \"method\": \"Morpholino knockdown in zebrafish; transgenic reporter lines; molecular marker analysis\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic redundancy demonstrated by double morphant phenotype with arteriovenous marker analysis, replicated by independent zebrafish lab\",\n      \"pmids\": [\"18094332\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Sox17 and Sox18 have redundant roles in early cardiovascular development in mice: Sox17/Sox18 double-null embryos display more severe defects in anterior dorsal aorta and head/cervical microvasculature than Sox17 single-null, corresponding to sites of weak Sox7 expression.\",\n      \"method\": \"Double knockout mouse generation; whole-mount PECAM staining\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic double knockout with defined vascular phenotypes and epistasis mapping\",\n      \"pmids\": [\"17610846\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Sox18 acts as a molecular switch to induce differentiation of lymphatic endothelial cells: it is expressed in cardinal vein cells that co-express Prox1 and form lymphatic vessels; Sox18 directly activates Prox1 transcription by binding to its proximal promoter; overexpression of Sox18 in blood vascular endothelial cells induces Prox1 and other lymphatic markers; Sox18-null embryos on a sensitized background show complete blockade of lymphatic endothelial differentiation from the cardinal vein.\",\n      \"method\": \"Promoter binding assay; overexpression in endothelial cells; Sox18-null mouse embryo analysis; cellular lineage tracing\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — direct promoter binding, gain-of-function, and loss-of-function experiments with defined lymphatic differentiation phenotype\",\n      \"pmids\": [\"18931657\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"In zebrafish, simultaneous knockdown of Sox7 and Sox18 causes dysmorphogenesis of the proximal aorta and arteriovenous shunts; morphants display ectopic venous Flt4 marker in the dorsal aorta and reduced artery-specific markers EphrinB2a and Gridlock, suggesting Sox7/Sox18 control arteriovenous identity by regulating Gridlock expression.\",\n      \"method\": \"Morpholino knockdown in zebrafish; gene expression analysis by ISH and RT-PCR\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — double morphant phenotype replicated across two zebrafish labs with molecular marker analysis\",\n      \"pmids\": [\"18377889\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Sox7 and Sox17 can functionally substitute for SOX18 in vitro and in vivo as strain-specific modifiers: they are not normally expressed during lymphatic development but are activated specifically in the absence of SOX18 function only in certain mouse strains, revealing a novel compensatory upregulation mechanism.\",\n      \"method\": \"Genetic modifier analysis; in vitro functional substitution assays; expression analysis in Sox18-null mice on different strain backgrounds\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — mechanistic epistasis combined with in vitro and in vivo functional rescue experiments\",\n      \"pmids\": [\"19515696\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"In Ra-Op embryos, SOX18 dysfunction causes enlarged surface capillaries and endothelial barrier breaches by 12.5 dpc with endothelial hyperplasia and impaired pericyte recruitment; downstream targets MMP7, IL7R, and N-cadherin are reduced, implicating SOX18 in transcriptional regulation of genes required for microvascular maturation.\",\n      \"method\": \"Ultrastructural analysis (EM); immunofluorescence; molecular expression analysis in Ra-Op embryos\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — multiple orthogonal methods (EM, IHC, gene expression) in a defined mutant model, single lab\",\n      \"pmids\": [\"19429912\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"SOX18 is a potential target for anti-angiogenic cancer therapy: disruption of Sox18 function (Sox18-null or dominant-negative Sox18RaOp mice) reduces allograft tumor growth and microvessel density; dominant-negative SOX18 impairs HUVEC proliferation, migration, and capillary tube formation via disruption of the actin cytoskeleton.\",\n      \"method\": \"Allograft tumor model in Sox18-null and Sox18RaOp mice; BrdU incorporation; MTS assay; Boyden chamber migration; capillary tube formation in vitro\",\n      \"journal\": \"Journal of the National Cancer Institute\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple functional readouts in vitro and in vivo, but mechanistic detail limited to actin cytoskeleton disruption\",\n      \"pmids\": [\"16882943\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"EGR1 transcription factor directly activates the SOX18 promoter: three EGR1 binding sites between -89 and +29 bp relative to the transcriptional start site are functionally required for EGR1-induced SOX18 transcription, as shown by in vitro binding assays and mutational analysis.\",\n      \"method\": \"SOX18 promoter reporter assays; in vitro binding assays; site-directed mutagenesis of EGR1 binding sites\",\n      \"journal\": \"Experimental & molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Weak — in vitro binding and functional mutagenesis, single lab\",\n      \"pmids\": [\"20054233\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Transcription factors Sp3 and ZBP-89 down-regulate, while NF-Y up-regulates, human SOX18 promoter activity by binding the SOX18 promoter region (-200 to -162 bp relative to ATG), as demonstrated by in vitro binding assays and co-transfection experiments.\",\n      \"method\": \"In vitro binding assays; co-transfection reporter assays; mithramycin A treatment\",\n      \"journal\": \"Molecular biology reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — direct binding and functional transcription assays, single lab\",\n      \"pmids\": [\"18496767\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"SOX18 directly activates MMP7 transcription in endothelial cells (demonstrated by promoter reporter assay, EMSA, and ChIP), and also regulates guidance molecules ephrin B2 and semaphorin 3G; SOX18 and MMP7 are co-expressed in blood vessels of human skin.\",\n      \"method\": \"Adenoviral overexpression; microarray; ChIP; EMSA; reporter gene assays; RT-PCR; immunohistochemistry\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — direct target validation by ChIP, EMSA, and promoter reporter assays with multiple orthogonal methods\",\n      \"pmids\": [\"22292085\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"VEGFD modulates SOX18-mediated transcription through MEK-ERK signaling, enhancing nuclear concentration and transcriptional activity of SOX18 in vascular endothelial cells; genetic interaction between Vegfd and Sox18 is required for normal vascular development in both zebrafish and mice.\",\n      \"method\": \"Zebrafish double morphant; Sox18/Vegfd double knockout mice; cell-based SOX18 transcription assay; signaling pathway analysis\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic interaction in two species combined with molecular mechanism (MAPK-ERK modulation of SOX18 nuclear activity)\",\n      \"pmids\": [\"24269955\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Sox18 genetically interacts with VegfC to regulate lymphangiogenesis: combined partial knockdown of sox18 and vegfc in zebrafish has synergistic effects on venous and lymphatic sprouting from the cardinal vein, and Sox18 is required specifically for lymphangiogenesis after arteriovenous differentiation.\",\n      \"method\": \"Zebrafish morpholino knockdown; inducible dominant-negative Sox18 transgenic zebrafish; thoracic duct formation analysis\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis in zebrafish with inducible dominant-negative model and morpholino double knockdown\",\n      \"pmids\": [\"23520166\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Sox18 maintains pulmonary endothelial barrier integrity in response to laminar shear stress by upregulating Claudin-5 (CLDN5): shear stress increases Sox18 expression; overexpression of Sox18 enhances trans-endothelial resistance; depletion of Claudin-5 abolishes the Sox18-mediated barrier effect.\",\n      \"method\": \"Trans-endothelial resistance measurement; Sox18 overexpression and knockdown; Claudin-5 siRNA; ovine shunt model\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional barrier assay with loss- and gain-of-function, downstream target validation by siRNA rescue\",\n      \"pmids\": [\"24677020\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Crystal structure of the SOX18 HMG box bound to a Prox1 DNA element determined at 1.75Å resolution reveals water structure, DNA contact interface, and non-canonical DNA backbone conformations; decoy DNAs based on the Prox1 binding site inhibit SOX18 DNA binding in vitro and suppress SOX18-dependent VCAM1 promoter activity in cells.\",\n      \"method\": \"X-ray crystallography; in vitro DNA binding assay; luciferase reporter assay in COS7 cells; serum stability and nuclease resistance assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure at high resolution with functional validation by decoy inhibition in cell-based reporter assay\",\n      \"pmids\": [\"26939885\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"NF-κB (p65) transcriptionally represses SOX18 expression by binding to a SOX18 promoter sequence between -1,082 and -1,073 bp; this NF-κB-mediated SOX18 downregulation leads to reduced CLDN5 and pulmonary endothelial barrier disruption in LPS-induced acute lung injury; peroxynitrite contributes to NF-κB activation in this context.\",\n      \"method\": \"Promoter reporter assays; ChIP for NF-κB; SOX18 overexpression in HLMVECs and mouse lung; CLDN5 siRNA rescue; LPS in vivo models\",\n      \"journal\": \"American journal of respiratory cell and molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP, promoter mapping, gain-of-function in vitro and in vivo, and downstream target rescue\",\n      \"pmids\": [\"29115856\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"A small molecule (Sm4) disrupts a discrete subset of SOX18 protein-protein interactions involving the HMG DNA-binding domain, including SOX18-RBPJ interaction, selectively suppresses SOX18 transcriptional outputs in vitro, interferes with vascular development in zebrafish, and reduces tumour vascular density and metastatic spread in a mouse breast cancer model.\",\n      \"method\": \"Proteomic interactome analysis; biophysical binding assays; zebrafish vascular development assay; mouse breast cancer allograft model; reporter gene assay\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods (proteomics, biophysics, cell-based reporter, in vivo models) in a single comprehensive study\",\n      \"pmids\": [\"28137359\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Small-molecule SOX18 inhibitors identified from a marine extract library interfere with the SOX18 HMG DNA-binding domain, disrupt HMG-dependent protein-protein interaction with RBPJ, and perturb SOX18 transcriptional activity in a cell-based reporter system.\",\n      \"method\": \"Marine extract library screen; in vitro binding assay; cell-based SOX18 reporter gene assay\",\n      \"journal\": \"Cell chemical biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical binding assay and cell-based reporter, single lab, multiple compounds tested\",\n      \"pmids\": [\"28163017\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"SOX18 regulates the differentiation of dermal papilla in all hair types: dominant-negative Sox18 (opossum) prevents dermal papilla from inducing hair in regeneration assays; downstream effectors WNT5A and TNC are identified by microarray as potential SOX18 targets regulating epidermal WNT signalling.\",\n      \"method\": \"Dominant-negative Sox18 mouse; fate tracing; microarray; hair regeneration assay with dermal papilla spheres\",\n      \"journal\": \"Development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — dominant-negative loss-of-function with defined hair differentiation phenotype and microarray target identification, single lab\",\n      \"pmids\": [\"28512199\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"SOX18 uniquely forms homodimers (among SOXF proteins) via a novel motif in the vicinity of the C-terminus of the DNA-binding region; SOX18 dimerization drives enrichment at endothelial-specific chromatin loci containing SOX dimer binding motifs; a small-molecule inhibitor that disrupts dimerization reduces SOX18 transcriptional activity.\",\n      \"method\": \"In vitro binding assays; split-GFP dimerization reporter in zebrafish; genome-wide ChIP-seq; SOX18 dimerization inhibitor; motif insertion into SOX7 monomer\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro binding, in vivo split-GFP, genome-wide ChIP-seq, and pharmacological disruption with functional readout\",\n      \"pmids\": [\"30335167\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"miR-7-5p targets the SOX18 3'UTR to suppress SOX18 protein expression, and SOX18 transcriptionally activates gp130 (a subunit of the IL-6 receptor), activating gp130/JAK2/STAT3 signaling in pancreatic cancer cells.\",\n      \"method\": \"Luciferase reporter assay (miRNA target); Western blot; ChIP assay for SOX18 on gp130 promoter; gp130/JAK2/STAT3 pathway analysis\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — ChIP for direct target validation and pathway analysis, single lab\",\n      \"pmids\": [\"29408481\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"R(+)-propranolol is a small-molecule inhibitor of the SOX18 transcription factor, acting independently of beta-adrenergic receptor blockade; this mechanism explains propranolol's therapeutic effect in infantile hemangioma and HLTRS syndrome, and is demonstrated in a mouse model of HLTRS (corneal neo-vascularisation rescue) and a patient-derived hemangioma model.\",\n      \"method\": \"Mouse HLTRS model; in vitro infantile hemangioma model; molecular mechanism dissection distinguishing R(+) from S(-) enantiomer\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — enantiomer specificity ruling out adrenergic mechanism, in vivo and patient-derived model rescue, convergent evidence\",\n      \"pmids\": [\"31358114\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"SOX18 transcriptionally activates MCAM and CCL7, which are required for SOX18-mediated gastric cancer invasion and metastasis; a CCL7-CCR1-SOX18 positive feedback loop operates via the ERK/ELK1 pathway, where CCL7-CCR1 upregulates SOX18 expression.\",\n      \"method\": \"ChIP; luciferase reporter assay; gain/loss-of-function in GC cells; in vivo mouse models; rescue experiments with MCAM and CCL7\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP for direct target identification, rescue experiments, and signaling pathway dissection, single lab\",\n      \"pmids\": [\"32616889\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"TGF-β1 upregulates SOX18 expression by activating the Smad2/3 complex; SOX18 then transactivates CXCL12 and PD-L1, promoting immunosuppressive tumor microenvironment in hepatocellular carcinoma.\",\n      \"method\": \"ChIP; dual-luciferase reporter assay; flow cytometry; orthotopic allografts; hepatocyte-specific knockin/knockout mice; AAV8 delivery\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — ChIP and reporter assays for direct transcriptional targets, Smad2/3 upstream pathway, multiple in vivo models\",\n      \"pmids\": [\"38417530\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"SLC12A5 interacts with and stabilizes SOX18 protein, and the SLC12A5-SOX18 complex upregulates MMP7 to enhance bladder urothelial carcinoma progression.\",\n      \"method\": \"Co-immunoprecipitation; in vitro and in vivo functional assays; gene expression analysis\",\n      \"journal\": \"Cancer science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single Co-IP demonstrating interaction, functional assays performed but mechanistic detail limited\",\n      \"pmids\": [\"32449280\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"SOX18 enhances KSHV genome copy numbers and binds to viral origins of replication in lymphatic endothelial cells; chemical or genetic inhibition of SOX18 reduces KSHV genome copies, supporting a role for SOX18 in viral genome maintenance.\",\n      \"method\": \"ChIP for SOX18 on viral origins of replication; genetic depletion; chemical inhibition; quantification of viral genome copies\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and functional depletion experiments with defined viral copy number readout, single lab\",\n      \"pmids\": [\"32518203\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Dominant-negative SOX18 (SOX18RaOp) disrupts multiple functional layers of wild-type SOX18: it alters target gene selection genome-wide, impairs chromatin binding dynamics, and poisons the wild-type SOX18 interactome including regulatory nodes SOX7 and MEF2C; revealed by single-molecule imaging in living cells, genomics, and proteomics.\",\n      \"method\": \"Single-molecule imaging (three assays); genome-wide ChIP/ATAC-seq; proteomics interactome analysis; comparison of wild-type vs. dominant-negative in living cells\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal cutting-edge methods in a single comprehensive mechanistic study\",\n      \"pmids\": [\"34570228\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"NF-κB-mediated repression of Sox18 in LPS-induced acute lung injury requires HDAC1 and HDAC2: selective siRNA depletion of HDACs 1 and 2 prevents LPS-mediated Sox18 repression; HDAC1 associates with a transcription-repressive complex at the NF-κB-binding site of the Sox18 promoter; HDAC1 inhibitor tacedinaline preserves endothelial barrier in vivo.\",\n      \"method\": \"HDAC siRNA depletion; ChIP for HDAC1 at Sox18 promoter; promoter reporter assays; endothelial permeability assays; mouse LPS model\",\n      \"journal\": \"Frontiers in physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP for chromatin-associated repressor, siRNA depletion, and in vivo rescue, multiple orthogonal methods\",\n      \"pmids\": [\"35991176\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"SOX18 loss-of-function mutation (Lys117*) abolishes trans-activation on target genes NR2F2 and GATA4 and terminates synergistic activation between SOX18 and NKX2.5 in a luciferase reporter assay, identifying NR2F2 and GATA4 as direct transcriptional targets of SOX18 relevant to congenital heart disease.\",\n      \"method\": \"Luciferase reporter assay in HeLa cells; Sanger sequencing; co-transfection with SOX18/NKX2.5\",\n      \"journal\": \"Diagnostics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — cell-based reporter assay with defined mutant, single lab\",\n      \"pmids\": [\"36010266\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"SOX18 transcriptionally represses PTX3 under physiological conditions; in sepsis-induced cardiomyopathy, RBM15/YTHDF2-mediated m6A modification destabilizes SOX18 mRNA, reducing SOX18 protein, increasing PTX3, and inducing cardiomyocyte pyroptosis.\",\n      \"method\": \"ChIP; dual-luciferase reporter assay for SOX18-PTX3; m6A-seq; RNA stability assay; co-immunoprecipitation; confocal microscopy; mouse LPS cardiomyocyte model\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — ChIP and reporter assay for direct target, m6A-seq and RNA stability for PTM mechanism, multiple orthogonal methods in single study\",\n      \"pmids\": [\"40093897\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"An endothelial SOX18-mevalonate pathway (MVP) axis regulates infantile hemangioma pathogenesis: R(+)-propranolol suppresses the MVP via SOX18, which is both necessary and sufficient for this suppression; SOX18 regulates SREBP2 and HMG-CoA reductase (HMGCR); nuclear co-localization of SOX18 and SREBP2 is found in IH patient tissue; statins (HMGCR inhibitors) suppress IH vessel formation in a preclinical xenograft model.\",\n      \"method\": \"Transcriptomic profiling; SOX18 loss- and gain-of-function; IH xenograft model; patient tissue co-localization by IHC\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — transcriptomic, functional loss/gain-of-function, patient tissue validation, and in vivo xenograft model\",\n      \"pmids\": [\"39998898\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"TNF-α (as well as IL-1 and LPS) represses Sox18 expression in HUVECs through the NF-κB pathway (p65/RelA subunit); adenoviral expression of IκBα prevents Sox18 downregulation; the responsible SOX18 promoter region is within -1.0 kb of the transcriptional start site.\",\n      \"method\": \"Adenoviral IκBα overexpression; Sox18 promoter reporter assays; co-transfection with p65\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — promoter reporter and IκBα rescue, single lab, limited mechanistic depth\",\n      \"pmids\": [\"24269235\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SOX18 is an HMG-box transcription factor that binds the consensus motif AACAAAG and contains multiple transactivation domains (central, and a C-terminal 9-aa TAF9-interacting motif); it functions as a molecular switch for lymphatic endothelial cell differentiation by directly activating Prox1 transcription, and has direct transcriptional targets including VCAM-1, MMP7, CLDN5, CXCL12, PD-L1, gp130, MCAM, and CCL7; it physically interacts with MEF2C (required for vascular transcriptional programs), dimerizes via a unique C-terminal motif to access endothelial-specific chromatin loci, and is regulated upstream by VEGFD-MEK-ERK, TGF-β1-Smad2/3, EGR1, NF-κB (repressor, requiring HDAC1/2), Sp3, ZBP-89 (repressors), and NF-Y (activator); the R(+)-propranolol enantiomer and the small molecule Sm4 inhibit SOX18 activity by disrupting protein-protein interactions, and m6A modification by RBM15/YTHDF2 destabilizes SOX18 mRNA in sepsis; dominant-negative ragged alleles act by impairing MEF2C interaction and poisoning the wild-type SOX18 interactome including SOX7.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"SOX18 is an HMG-box transcription factor that orchestrates vascular and lymphatic endothelial development by binding the Sox consensus motif AACAAAG and trans-activating target genes through a mapped central activation domain (residues 160–225) and a C-terminal 9-amino-acid motif that recruits the cofactor TAF9 [#0, #9]. Its central developmental role is to act as a molecular switch for lymphatic endothelial differentiation, directly activating Prox1 transcription from cardinal vein cells and inducing the lymphatic program when overexpressed in blood vascular endothelium [#12]. SOX18 functions within the SOXF family with extensive redundancy: it shares overlapping roles with Sox7 and Sox17 in arteriovenous identity, neovascularization, and early cardiovascular patterning, such that Sox18-null mice are largely normal while combined loss produces severe vascular defects [#2, #8, #10, #11]. Beyond Prox1, SOX18 directly activates an endothelial and disease-relevant target repertoire including VCAM-1, MMP7, and the barrier protein Claudin-5 [#7, #19, #22], and it cooperates with the MADS-box factor MEF2C, which potentiates SOX18 activity through its activation domain [#3]. SOX18 uniquely homodimerizes among SOXF proteins via a C-terminal motif, and this dimerization drives its enrichment at endothelial-specific chromatin loci [#28]. Its activity is shaped by upstream signaling, being enhanced by VEGFD-MEK-ERK signaling that increases nuclear SOX18 [#20] and TGF-β1–Smad2/3 [#32], and repressed at the promoter by NF-κB acting through HDAC1/2 [#24, #36]. Dominant-negative \\\"ragged\\\" alleles cause cardiovascular and hair follicle defects not by haploinsufficiency but by poisoning the wild-type SOX18 interactome, including loss of MEF2C and SOX7 contacts and disrupted chromatin binding dynamics [#1, #2, #35]. SOX18 is a druggable node: small molecules such as Sm4 and the R(+)-propranolol enantiomer inhibit its protein-protein interactions, explaining propranolol's efficacy in infantile hemangioma and HLTRS syndrome [#25, #30]. In cancer it drives tumor angiogenesis, invasion, and an immunosuppressive microenvironment through targets including gp130, MCAM, CCL7, CXCL12, and PD-L1 [#16, #29, #31, #32].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Established SOX18 as a sequence-specific DNA-binding transcriptional activator with a defined activation domain, answering whether it functions directly on gene promoters.\",\n      \"evidence\": \"In vitro DNA binding with bacterially expressed protein and GAL4-SOX18 fusion trans-activation assays\",\n      \"pmids\": [\"7651823\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No physiological target genes identified at this stage\", \"Cellular and developmental context unknown\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Linked SOX18 to cardiovascular and hair follicle development and revealed that disease-causing ragged alleles act dominant-negatively rather than through simple loss of function.\",\n      \"evidence\": \"Sequencing of Ra alleles with in vitro transcription assays, plus Sox18-null mouse phenotyping\",\n      \"pmids\": [\"10742113\", \"11094083\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of the dominant-negative effect not yet defined\", \"Identity of redundant compensating factors only inferred\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Identified MEF2C as a direct SOX18 partner that potentiates its activity and explained the dominant-negative ragged effect as loss of MEF2C interaction.\",\n      \"evidence\": \"Co-immunoprecipitation, endothelial co-localization, and co-transfection transcription assays with wild-type and mutant SOX18\",\n      \"pmids\": [\"11554755\", \"12748961\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of the SOX18-MEF2C interface not resolved\", \"Whether MEF2C cooperation is needed at all endothelial targets unknown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Defined the first direct in vivo endothelial target gene, VCAM-1, establishing SOX18 control of vascular adhesion gene expression.\",\n      \"evidence\": \"EMSA, site-directed promoter mutagenesis, and qRT-PCR in Ra-Op mutant mice\",\n      \"pmids\": [\"14634005\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Broader genome-wide target set not yet mapped\", \"Mechanism of target selectivity unknown\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Resolved redundancy within the SOXF family, showing Sox7/Sox17/Sox18 collectively govern arteriovenous identity and neovascularization across mouse and zebrafish.\",\n      \"evidence\": \"Double-mutant mice and double-morphant zebrafish with vascular marker analysis (Gridlock, EphrinB2, Flt4)\",\n      \"pmids\": [\"16895970\", \"18094332\", \"17610846\", \"18377889\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Division of labor among paralogs at specific loci unresolved\", \"Direct downstream effectors of arteriovenous patterning incompletely defined\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Defined a second transactivation module — a C-terminal 9-aa motif binding TAF9 — reconciling contradictory data on truncating SOX18 mutations.\",\n      \"evidence\": \"Deletion mapping, GAL4 reporter assays, and TAF9 interaction analysis\",\n      \"pmids\": [\"17603017\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Contribution of this domain in vivo not directly tested\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Established SOX18 as the molecular switch initiating lymphatic endothelial differentiation by directly activating Prox1, the field-defining mechanistic insight.\",\n      \"evidence\": \"Proximal Prox1 promoter binding, gain-of-function in blood endothelium, and Sox18-null embryo analysis on a sensitized background\",\n      \"pmids\": [\"18931657\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream signals triggering the switch not fully defined at this stage\", \"Cofactor requirements for Prox1 activation unspecified\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Explained strain-dependent severity of Sox18 loss through compensatory upregulation of normally silent Sox7/Sox17, and detailed microvascular maturation defects in ragged mutants.\",\n      \"evidence\": \"Genetic modifier analysis, functional substitution assays, and ultrastructural/expression analysis of Ra-Op embryos (MMP7, IL7R, N-cadherin)\",\n      \"pmids\": [\"19515696\", \"19429912\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism that activates compensatory paralog expression unknown\", \"Pericyte recruitment defect not mechanistically linked to specific targets\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Began mapping upstream transcriptional control of the SOX18 promoter, identifying activators and repressors.\",\n      \"evidence\": \"Promoter reporter assays, in vitro binding, and mutagenesis for EGR1, Sp3, ZBP-89, and NF-Y\",\n      \"pmids\": [\"20054233\", \"18496767\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo relevance of these regulators not tested\", \"Integration of multiple inputs on the promoter unresolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Connected vascular growth-factor signaling to SOX18, showing VEGFD-MEK-ERK enhances nuclear SOX18 activity and VegfC genetically interacts with sox18 in lymphangiogenesis.\",\n      \"evidence\": \"Zebrafish and mouse genetic interaction studies with cell-based SOX18 transcription assays; inducible dominant-negative zebrafish\",\n      \"pmids\": [\"24269955\", \"23520166\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct ERK phosphorylation sites on SOX18 not mapped\", \"Quantitative contribution of each signal in vivo unclear\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Defined a SOX18-Claudin-5 axis maintaining endothelial barrier integrity under shear stress, linking SOX18 to vascular homeostasis beyond development.\",\n      \"evidence\": \"Trans-endothelial resistance with SOX18 gain/loss-of-function and Claudin-5 siRNA rescue, ovine shunt model\",\n      \"pmids\": [\"24677020\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanosensing pathway upstream of SOX18 not defined\", \"Other barrier targets not assessed\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Provided a high-resolution structural basis for SOX18-DNA recognition and demonstrated druggability via DNA decoys, alongside NF-κB-mediated promoter repression in lung injury.\",\n      \"evidence\": \"1.75Å crystal structure of the HMG box on a Prox1 element with decoy inhibition; ChIP and promoter mapping of NF-κB repression\",\n      \"pmids\": [\"26939885\", \"29115856\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length protein and dimer structure not solved\", \"Structural basis of cofactor contacts unknown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Validated SOX18 protein-protein interactions as a therapeutic vulnerability and identified small molecules (Sm4, marine extracts) and R(+)-propranolol that disrupt them, mechanistically explaining propranolol efficacy in hemangioma and HLTRS.\",\n      \"evidence\": \"Interactome proteomics, biophysical binding, cell reporters, zebrafish and mouse tumor/HLTRS models; enantiomer-specific dissection\",\n      \"pmids\": [\"28137359\", \"28163017\", \"31358114\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise binding sites of inhibitors on SOX18 not all resolved\", \"Selectivity against other SOXF proteins incompletely characterized\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Discovered that SOX18 uniquely homodimerizes among SOXF proteins via a C-terminal motif, and that dimerization drives enrichment at endothelial-specific chromatin loci.\",\n      \"evidence\": \"In vitro binding, split-GFP dimerization in zebrafish, genome-wide ChIP-seq, motif transfer to monomeric SOX7, and a dimerization-disrupting inhibitor\",\n      \"pmids\": [\"30335167\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether all endothelial targets require dimerization unknown\", \"Structural detail of the dimer interface not solved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Defined the multilayered mechanism of the dominant-negative ragged allele, showing it rewires target selection, chromatin binding dynamics, and the wild-type interactome including SOX7 and MEF2C.\",\n      \"evidence\": \"Single-molecule live-cell imaging, genome-wide ChIP/ATAC-seq, and interactome proteomics comparing wild-type and SOX18RaOp\",\n      \"pmids\": [\"34570228\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of poisoning in heterozygous tissue not quantified\", \"Therapeutic reversibility not tested\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Extended SOX18 mechanism to disease metabolism and post-transcriptional control, linking it to a mevalonate-pathway axis in hemangioma and to m6A-mediated mRNA destabilization in sepsis cardiomyopathy.\",\n      \"evidence\": \"Transcriptomics with SOX18 gain/loss and IH xenografts; ChIP, m6A-seq, RNA stability, and Co-IP in LPS cardiomyocyte models (SREBP2/HMGCR; RBM15/YTHDF2/PTX3)\",\n      \"pmids\": [\"39998898\", \"40093897\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Generalizability of the mevalonate axis beyond hemangioma unknown\", \"Whether m6A regulation operates in vascular tissues untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How SOX18's two transactivation domains, homodimerization, and partner contacts (MEF2C, TAF9, RBPJ, SOX7) are integrated structurally and combinatorially to achieve locus-specific endothelial gene selection remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No full-length or dimer-DNA-cofactor structure\", \"Rules governing target selectivity across cell types undefined\", \"Quantitative hierarchy of upstream signaling inputs unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 12, 7, 19, 32]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 23, 28]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [3, 20]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [12, 8, 11]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 7, 19]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [20, 32]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [30, 31, 32]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"MEF2C\", \"SOX7\", \"TAF9\", \"RBPJ\", \"NKX2.5\", \"SLC12A5\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":9,"faith_total":9,"faith_pct":100.0}}